Latest news
Rein Therapeutics (NASDAQ:RNTX) Shares Down 2.9% - Here's Why - MarketBeatMarketBeat · Tue, 11 Aug 2026 05:04:59 GMTRNTX: Q3 net loss widened to $5.8M; positive LTI-03 data, but cash only funds operations into June 2025 - TradingViewTradingView · Sun, 09 Aug 2026 09:33:36 GMTRein Therapeutics Inc (RNTX) Stock News Today - TradingKeyTradingKey · Fri, 07 Aug 2026 07:56:40 GMTRNTX PE Ratio & Valuation, Is RNTX Overvalued - Intellectia AIIntellectia AI · Thu, 06 Aug 2026 05:11:13 GMTRNTX Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:31 GMTRein Therapeutics Inc (RNTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Wed, 05 Aug 2026 07:00:00 GMTRein's Inhaled LTI-03 Reduced Lung-Scarring Markers After 14 Days - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTRein Therapeutics (RNTX) Dips 2.76% to $0.74, Pressing Against Key Support - Quality ETF - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 20:38:04 GMT